Biologic Biosimilar Switzerland Europe,Biological Biosimilar Amgen Oncology,Biopharmaceutical Biosimilar Representation Biogeneric,Business Strategy Pricing Distributor,Development Regulatory Clinical Biosimilar,Licensing Product Device Oncology


 
                               Header29.png

 
Home PageAbout UsSearchContact UsSite Map

 

Client Assignment examples

  • M&A: Sale of biotechnology company (leading platform technology related to mAb’s development in mammalian cell lines)
  • M&A: Acquisition of privately owned pharmaceutical company
  • Licensing: Pan-European out-licensing of a biosimilar
  • Licensing: In-licensing of biosimilar and originator biological products
  • Project: Due Diligence of biosimilar products and companies
  • Project: Consulting and generating Information Memorandum for funding biosimilar company
  • Management: Strategic advice for and establishing/implementing an international pharmaceutical trading company in Switzerland.
  • Management: Strategic advice for executive management on business development strategies.
  • Technical: Pre-audit of development process and manufacturing facility of a biosimilar medicinal product in a Chinese manufacturing facility (analytical quality of product, upstream and downstream processing, gap analysis measured towards EMEA requirements for biosimilars), and subsequent strategic advice in terms of development process, manufacturing, pre-clinical and clinical studies, regulatory strategy, financial and time requirements.

 
 
Home Page | About Us | Search | Contact Us | Site Map